This English-language Master's program is an advanced, research-focused continuation of undergraduate study in the life sciences. It is aimed at graduates who want to move beyond foundational coursework and concentrate on the molecular basis of cell and organ function as well as disease processes. The curriculum combines in-depth theoretical training with substantial laboratory practice to develop both conceptual understanding and technical competence.
You will study molecular pathways that control cell proliferation, differentiation and programmed cell death, plus the physiology of cells and organs and the pathophysiology underlying human disease. Alongside these topics, the program places emphasis on improving practical laboratory skills so you gain hands-on experience with experimental techniques commonly used in molecular and biomedical research.
The degree is intended for students who already hold a relevant Bachelor’s qualification in the life sciences and who wish to broaden and deepen their expertise before pursuing careers or further research in molecular biomedical fields.
Requirements (concise)
This two‑year, interdisciplinary Master's programme is delivered entirely in English: lectures, seminars, practical courses and examinations are all taught and assessed in English. The curriculum spans four semesters. In the first semester you build advanced theoretical foundations (cell and developmental biology, bioinformatics and systems biology, pharmacology and drug development) and complete an intensive three‑week laboratory practical to develop core bench skills.
Semesters two and three emphasize hands‑on research training. Students choose from four main subject blocks—Molecular Oncology, Trauma and Infection, Cell Biology and Toxicology—each offered as seminar series plus a four‑week practical; two blocks are taken per semester. In parallel, the programme includes shorter, career‑oriented modules that broaden beyond bench science, covering Clinical Trials, Bioethics, Good Scientific Practice, and Project Management & Funding. The fourth semester is dedicated to the practical Master’s thesis, which concludes with an oral disputation at the end of the programme.
Students can apply (after admission, during year one) to two international double‑degree tracks with partner universities in Padua (Italy) and Oulu (Finland) or to one of two specialisation pathways (Molecular Oncology or Toxicology); you may participate in only one of these options. The full study plan is available here: https://www.uni-ulm.de/fileadmin/website_uni_ulm/med/01_StudiumUndLehre/02_Studienangebot/3_MolMed/Master_Studienplan_Molekulare_Medizin.pdf
Key modules and practical elements
Learning outcomes (what you will be able to do)
Admissions overview
To apply you must already have completed—or be in the final stages of completing—a relevant undergraduate degree that provides a solid molecular medicine foundation. Degrees may come from a university, a university of applied sciences, a cooperative university, or a recognised foreign higher education institution and must represent at least three years of full-time study, proven by an academic final examination (Bachelor’s degree).
Academic performance thresholds are required: applicants with a finished Bachelor’s degree must have an overall grade of 2.5 or better; if the Bachelor’s degree has not yet been awarded at the time of application, the current average of examination results must be 2.7 or better. If your degree or grades come from outside Germany, the Admission Office of the Medical Faculty will check grade equivalence, and the Master’s Commission decides whether your study programme is considered equivalent.
Admission requirements (summary)
Winter Semester (International)
15 May 2026
Winter Semester (EU/EEA)
15 May 2026
Graduates are prepared for research and development roles in academia, pharmaceutical and biotechnology industry, clinical research units, diagnostic companies, and regulatory or quality-control laboratories. The programme's emphasis on practical laboratory skills and specialised modules (oncology, toxicology, pharmacology) equips students for technical and project-based laboratory positions as well as roles in translational research and clinical trial teams.
The degree also provides a solid foundation for doctoral studies (PhD) and research careers. Participation in the double degree options and international semesters further enhances employability for cross-border research collaborations and positions in international organisations, science policy or science management roles.
Technical University of Munich — München
Technical University of Munich — München
Hochschule Fresenius - University of Applied Sciences — Berlin
Dresden International University — Dresden